363 related articles for article (PubMed ID: 34737226)
1. COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension.
Hoeper MM; Pausch C; Olsson KM; Huscher D; Pittrow D; Grünig E; Staehler G; Vizza CD; Gall H; Distler O; Opitz C; Gibbs JSR; Delcroix M; Ghofrani HA; Park DH; Ewert R; Kaemmerer H; Kabitz HJ; Skowasch D; Behr J; Milger K; Halank M; Wilkens H; Seyfarth HJ; Held M; Dumitrescu D; Tsangaris I; Vonk-Noordegraaf A; Ulrich S; Klose H; Claussen M; Lange TJ; Rosenkranz S
Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 34737226
[TBL] [Abstract][Full Text] [Related]
2. External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry.
Boucly A; Weatherald J; Savale L; de Groote P; Cottin V; Prévot G; Chaouat A; Picard F; Horeau-Langlard D; Bourdin A; Jutant EM; Beurnier A; Jevnikar M; Jaïs X; Simonneau G; Montani D; Sitbon O; Humbert M
Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 34737227
[TBL] [Abstract][Full Text] [Related]
3. Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis.
Rosenkranz S; Pausch C; Coghlan JG; Huscher D; Pittrow D; Grünig E; Staehler G; Vizza CD; Gall H; Distler O; Delcroix M; Ghofrani HA; Ewert R; Kabitz HJ; Skowasch D; Behr J; Milger K; Halank M; Wilkens H; Seyfarth HJ; Held M; Scelsi L; Neurohr C; Vonk-Noordegraaf A; Ulrich S; Klose H; Claussen M; Eisenmann S; Schmidt KH; Remppis BA; Skride A; Jureviciene E; Gumbiene L; Miliauskas S; Löffler-Ragg J; Lange TJ; Olsson KM; Hoeper MM; Opitz C
J Heart Lung Transplant; 2023 Jan; 42(1):102-114. PubMed ID: 36333206
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysis.
Hoeper MM; Pausch C; Olsson KM; Huscher D; Pittrow D; Grünig E; Staehler G; Vizza CD; Gall H; Distler O; Opitz C; Gibbs JSR; Delcroix M; Ghofrani HA; Ewert R; Kaemmerer H; Kabitz HJ; Skowasch D; Behr J; Milger K; Halank M; Wilkens H; Seyfarth HJ; Held M; Dumitrescu D; Tsangaris I; Vonk-Noordegraaf A; Ulrich S; Klose H; Claussen M; Eisenmann S; Schmidt KH; Rosenkranz S; Lange TJ
J Heart Lung Transplant; 2022 Jul; 41(7):971-981. PubMed ID: 35430147
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the European Society of Cardiology/European Respiratory Society derived three- and four-strata risk stratification models in pulmonary arterial hypertension: introducing an internet-based risk stratification calculator.
Ahmed A; Ahmed S; Kempe D; Rådegran G
Eur Heart J Open; 2023 Mar; 3(2):oead012. PubMed ID: 36959867
[TBL] [Abstract][Full Text] [Related]
6. Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.
Hoeper MM; Kramer T; Pan Z; Eichstaedt CA; Spiesshoefer J; Benjamin N; Olsson KM; Meyer K; Vizza CD; Vonk-Noordegraaf A; Distler O; Opitz C; Gibbs JSR; Delcroix M; Ghofrani HA; Huscher D; Pittrow D; Rosenkranz S; Grünig E
Eur Respir J; 2017 Aug; 50(2):. PubMed ID: 28775047
[TBL] [Abstract][Full Text] [Related]
7. Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension.
Chin KM; Rubin LJ; Channick R; Di Scala L; Gaine S; Galiè N; Ghofrani HA; Hoeper MM; Lang IM; McLaughlin VV; Preiss R; Simonneau G; Sitbon O; Tapson VF
Circulation; 2019 May; 139(21):2440-2450. PubMed ID: 30982349
[TBL] [Abstract][Full Text] [Related]
8. The Consistent Effectiveness and Safety of Macitentan Therapies Across Idiopathic and Congenital Heart Disease-Associated PulmonaryArterial Hypertension: A Single-Center Experience.
Kaymaz C; Tanyeri S; Tokgöz HC; Akbal ÖY; Karagöz A; Keskin B; Kültürsay B; Hakgör A; Külahçıoğlu Ş; Bayram Z; Efe SÇ; Tanboğa İH; Doğan C; Akbulut M; Özdemir N
Anatol J Cardiol; 2022 Oct; 26(10):778-787. PubMed ID: 36196862
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the European Society of Cardiology Risk Assessment Score in Incident Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
Brown Z; Hansen D; Stevens W; Ferdowsi N; Ross L; Quinlivan A; Sahhar J; Ngian GS; Apostolopoulos D; Walker JG; Proudman S; Teng GG; Low AHL; Morrisroe K; Nikpour M
Arthritis Care Res (Hoboken); 2024 Jul; 76(7):973-983. PubMed ID: 38523256
[TBL] [Abstract][Full Text] [Related]
10. A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines.
Dardi F; Manes A; Guarino D; Zuffa E; De Lorenzis A; Magnani I; Rotunno M; Ballerini A; Lo Russo GV; Nardi E; Galiè N; Palazzini M
Open Heart; 2021 Oct; 8(2):. PubMed ID: 34667092
[TBL] [Abstract][Full Text] [Related]
11. The Right Heart Network and Risk Stratification in Pulmonary Arterial Hypertension.
Haddad F; Contrepois K; Amsallem M; Denault AY; Bernardo RJ; Jha A; Taylor S; Arthur Ataam J; Mercier O; Kuznetsova T; Vonk Noordegraaf A; Zamanian RT; Sweatt AJ
Chest; 2022 May; 161(5):1347-1359. PubMed ID: 34774527
[TBL] [Abstract][Full Text] [Related]
12. Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry.
Chung L; Fairchild RM; Furst DE; Li S; Alkassab F; Bolster MB; Csuka ME; Derk CT; Domsic RT; Fischer A; Frech TM; Gomberg-Maitland M; Gordon JK; Hinchcliff M; Hsu V; Hummers LK; Khanna D; Medsger TAJ; Molitor JA; Preston IR; Schiopu E; Shapiro L; Hant F; Silver R; Simms R; Varga J; Steen VD; Zamanian RT
Clin Exp Rheumatol; 2017; 35 Suppl 106(4):106-113. PubMed ID: 27908301
[TBL] [Abstract][Full Text] [Related]
13. The Role of Noninvasive Endpoints in Predicting Long-Term Outcomes in Pulmonary Arterial Hypertension.
Wronski SL; Mordin M; Kelley K; Anguiano RH; Classi P; Shen E; Manaker S
Lung; 2020 Feb; 198(1):65-86. PubMed ID: 31722043
[TBL] [Abstract][Full Text] [Related]
14. Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Humbert M; Farber HW; Ghofrani HA; Benza RL; Busse D; Meier C; Hoeper MM
Eur Respir J; 2019 Jun; 53(6):. PubMed ID: 30923187
[TBL] [Abstract][Full Text] [Related]
15. Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL Registry.
Frantz RP; Farber HW; Badesch DB; Elliott CG; Frost AE; McGoon MD; Zhao C; Mink DR; Selej M; Benza RL
Chest; 2018 Jul; 154(1):126-135. PubMed ID: 29355551
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of brain natriuretic peptides in patients with pulmonary arterial hypertension: A systematic review and meta-analysis.
Hendriks PM; van de Groep LD; Veen KM; van Thor MCJ; Meertens S; Boersma E; Boomars KA; Post MC; van den Bosch AE
Am Heart J; 2022 Aug; 250():34-44. PubMed ID: 35533723
[TBL] [Abstract][Full Text] [Related]
17. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.
Boucly A; Weatherald J; Savale L; Jaïs X; Cottin V; Prevot G; Picard F; de Groote P; Jevnikar M; Bergot E; Chaouat A; Chabanne C; Bourdin A; Parent F; Montani D; Simonneau G; Humbert M; Sitbon O
Eur Respir J; 2017 Aug; 50(2):. PubMed ID: 28775050
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation effect of COMPERA 2.0 risk assessment model on prognosis of Chinese patients with pulmonary arterial hypertension].
Liang YR; Yang YC; Yang BL; Zeng QX; Liu BY; Zhao Q; Luo Q; Zhao ZH; Yang T; Liu ZH; Xiong CM
Zhonghua Yi Xue Za Zhi; 2023 May; 103(18):1410-1416. PubMed ID: 37150694
[No Abstract] [Full Text] [Related]
19. Congenital heart disease with pulmonary artery hypertension in an Asian cohort-initial report from TACHYON (TAiwan congenital heart disease associated with pulmonarY arterial hypertension) registry.
Chiu SN; Weng KP; Lin MC; Wang JN; Hwang BT; Dai ZK; Lin SM; Chang JS; Lin IC; Wu MH; Lu CW; Lin MT; Chen CA; Hua YC; Wu JM; Wang JK;
Int J Cardiol; 2020 Oct; 317():49-55. PubMed ID: 32522677
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Risk Stratification Scores in Pulmonary Arterial Hypertension: A Monocentric Retrospective Study at Lausanne University Hospital.
Vraka A; Yerly P; Aubert JD
Respiration; 2022; 101(6):565-576. PubMed ID: 35045412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
